BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19589101)

  • 1. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma.
    Giovanella L; Keller F; Ceriani L; Tozzoli R
    Clin Chem Lab Med; 2009; 47(8):952-4. PubMed ID: 19589101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.
    Preissner CM; O'Kane DJ; Singh RJ; Morris JC; Grebe SK
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3069-74. PubMed ID: 12843145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients.
    Verburg FA; Wäschle K; Reiners C; Giovanella L; Lentjes EG
    Horm Metab Res; 2010 Sep; 42(10):736-9. PubMed ID: 20486066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
    Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
    Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
    Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
    Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spurious increase in serum chromogranin A: the role of heterophilic antibodies.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2010 Oct; 48(10):1497-9. PubMed ID: 20666696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma.
    Giovanella L; Ghelfo A
    Clin Chem; 2007 Oct; 53(10):1871-2. PubMed ID: 17885144
    [No Abstract]   [Full Text] [Related]  

  • 12. Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.
    Lupoli GA; Barba L; Liotti A; La Civita E; Lupoli R; Riccio E; Portella G; Formisano P; Beguinot F; Terracciano D
    Medicine (Baltimore); 2019 Feb; 98(5):e14178. PubMed ID: 30702570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.